Background: Chemotherapy-induced peripheral neuropathy (CIPN), a side effect of chemotherapy, is particularly difficult to treat. We explored whether phosphosulindac (PS), a modified NSAID, could treat CIPN.
Methods: CIPN was induced in male C57BL/6 J mice by paclitaxel, vincristine or oxaliplatin.